Researchers create therapy that curbs toxic chemotherapy effects

Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel—a commonly used chemotherapy drug directly to a tumor.